-
Encourage enterprises and social third parties to participate in matters related to the formulation and revision of Chinese medicine standards
Time of Update: 2022-09-14
In order to further enhance the management capacity of Chinese medicine standards, establish the most rigorous standards, optimize the standard work mechanism, comprehensively build a new pattern of
-
State Food and Drug Administration: Revised the instructions for hydroxyethyl starch injections
Time of Update: 2022-09-14
According to the results of the evaluation of adverse drug reactions, in order to further protect the safety of public medication, the State Drug Administration decided to treat hydroxyethyl starch i
-
The latest progress in the adjustment of the medical insurance drug list in 2022: 344 drugs passed the preliminary form review
Time of Update: 2022-09-14
(CCTV reporter Zhang Ping Yizhe) On September 6, the National Medical Security Bureau announced the list of drugs that passed the preliminary form review in the adjustment of the national basic medical insurance, work injury insurance and maternity insurance drug catalogue in 2022, and 344 drugs passed the preliminary form review.
-
How should the pharmaceutical sector be laid out in the fourth quarter? There are 4 main lines recommended in the industry
Time of Update: 2022-09-14
Follow-up recommended under the guarantee of new infrastructure under the performance of the head enterprises such as Mindray Medical, the company in the first half of 2022 to achieve a total operating income of 15.
-
The new Agricultural Product Quality and Safety Law was promulgated and came into force on January 1, 2023
Time of Update: 2022-09-14
Decree of the President of the People's Republic of China No. 120 The Law of the People's Republic of China on the Quality and Safety of Agricultural Products was amended and adopted by the 36th Sess
-
The Chinese medicine industry has grown by nearly 200 billion yuan in 10 years! In the future, enterprises may focus on this section
Time of Update: 2022-09-14
In recent years, with the aging of the population, the continuous upgrading of consumption, and the promotion of a series of favorable policies, the industry combining traditional Chinese medicine and great health has received increasing attention, and the future market of traditional Chinese medicine health services has broad prospects.
-
The collection will be connected with the basic drug system, and the three types of drugs will not be included in the collection!
Time of Update: 2022-09-14
Recently, the official website of the National Medical Insurance Bureau has taken the initiative to publish a large number of replies to the proposals and suggestions of NPC deputies and CPPCC nation
-
Jingjing Pharmaceutical revenue increased, and raw materials such as Huanglian were affected by drought and increased prices!
Time of Update: 2022-09-14
Jingjing Pharmaceutical Group Co. , Ltd. (Jingjing Pharmaceutical, 002349) reported in the first half of 2022 that the company's operating income in the first half of the year was 792 million yuan, a
-
Under the vigorous development of the CXO industry, investment and financing may continue to be active!
Time of Update: 2022-09-14
The revenue and attributable net profit of the four companies increased by more than 50%, namely Boteng Shares, Gloria Ying, WuXi AppTec and Jiuzhou Pharmaceutical.
The revenue and attributable net profit of the four companies increased by more than 50%, namely Boteng Shares, Gloria Ying, WuXi AppTec and Jiuzhou Pharmaceutical.
-
Fruitful! The 2022 Service Trade Fair Health service topic was successfully concluded
Time of Update: 2022-09-14
As one of the nine thematic sections of the 2022 Service Trade Fair, the health and health service topic takes "Sunac Development and Shared Health" as the theme, aiming to create an integrated and open platform for international trade promotion, scientific and technological innovation, cultural exchange promotion, and investment cooperation in the field of health and health services, highlighting the pattern of China's health and health undertakings opening up to the outside world.
-
In 2022, the national medical insurance catalogue will be adjusted to drugs that have passed the preliminary form review
Time of Update: 2022-09-14
2022 National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue Adjustment Declared Drug Information through Preliminary Formal Examination National Medical Security Bureau September 6, 2022 Medical Insurance BureauMedical Insurance BureauDrugs
-
Sinovac's new crown vaccine approved in Chile for 6-month-old children
Time of Update: 2022-09-10
healthy children adverse reactions adverse reactions It is understood that as of now, Kexing’s new crown vaccine has been approved for vaccination of children and adolescents in 14 countries and regions including Indonesia, Thailand, Brazil, Chile, Colombia, etc.
-
Zhejiang centralized procurement 400 million market pattern reshapes 22 varieties "going to the examination room"
Time of Update: 2022-09-09
At present, the two batches of Zhejiang Province's centralized procurement have included 31 drugs, and the total sales in the province's public hospital terminals in 2021 will be about 400 million yuan.
-
The "Technical Guidelines for Influenza Vaccination in China" was released, and these groups are recommended to be vaccinated first
Time of Update: 2022-09-09
Based on the situation of the new crown pneumonia epidemic this year, the following key and high-risk groups are recommended to be vaccinated in a timely manner: medical personnel, including clinical treatment personnel, public health personnel, health quarantine personnel, etc.
-
Announcement of the State Food and Drug Administration on Suspension of Import, Sale and Use of Belgian UCB Pharma SA Levetiracetam Concentrated Solution for Injection
Time of Update: 2022-09-09
Recently, the State Food and Drug Administration organized an overseas off-site inspection of UCB Pharma SA in Belgium, and the inspected product was levetiracetam injection concentrated solution (Import Registration No.
-
How can traditional Chinese medicine go global?
Time of Update: 2022-09-09
" When it comes to the topic of internationalization of Chinese medicine, the China Academy of Chinese Medical Sciences Cao Hongxin, former president, chief researcher, vice president of China Intangible Cultural Heritage Protection Association and president of the Chinese Medicine Committee, said proudly .
-
National Health Commission: my country's health technology innovation capability has been significantly improved
Time of Update: 2022-09-09
The National Health Commission held a press conference today (August 25) to introduce the progress of health science and technology innovation and medical education since the 18th National Congress of the Communist Party of China .
-
Another 22 drugs were called out "dual-channel", and the classification of 49 countries has changed.
Time of Update: 2022-09-09
Standard Corporate Hospital Pharmacy Drugs On August 23, the Jiangxi Provincial Medical Insurance Bureau issued the "Announcement on the Dynamic Adjustment of the Classification and Management of Some National Medical Insurance Negotiated Drugs in Our Province".
-
"Sales Crown" broke 8 billion for the first time, and Renfu Medicine attacked sustained and controlled release preparations!
Time of Update: 2022-09-09
com, among the TOP10 oral sustained-release preparations in China's three major terminals and six major markets in 2021, the first on the list will exceed 8 billion yuan, 8 of which have been included in the national centralized procurement, and the third-ranked felodipine sustained-release tablet Or included in the eighth batch of centralized procurement, the market pattern will change .
-
High temperature and drought in Yunnan, Guizhou and Sichuan continue, can the market of fragrant sand usher in a turnaround?
Time of Update: 2022-09-09
Fragrant sand belongs to both medicinal and edible varieties, and the social demand is not large, and the market has been declining in the past 10 years .